Shoulder Innovations, Inc. (SI) Stock
Shoulder Innovations stock price chart
SI stock quote & key statistics
Shoulder Innovations annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $47.3M | -$40.4M | -$1.96 |
| FY2024 | $31.6M | -$15.6M | — |
| FY2023 | $19.3M | -$12.7M | — |
Fiscal year ending December 31. Source: company filings via EODHD.
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. engages in the provision of medical devices. It focuses on transforming the shoulder surgical care market. It also offers advanced implant systems for shoulder arthroplasty. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Shoulder Innovations stock FAQ
What is the Shoulder Innovations stock ticker symbol?
Shoulder Innovations, Inc. trades on the NYSE under the ticker symbol SI.
What were Shoulder Innovations's revenue and earnings last fiscal year?
Shoulder Innovations reported revenue of $47.3M and net income of -$40.4M in fiscal 2025, with earnings per share of -$1.96. Revenue grew 49.6% from the prior year.
Is Shoulder Innovations in the Russell 2000?
Yes. Shoulder Innovations, Inc. (SI) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did Shoulder Innovations go public?
Shoulder Innovations stock began trading on July 31, 2025.
Russell 2000 Healthcare stocks
All Russell 2000 →- ALKSAlkermes
- BTSGBrightSpring Health Services
- CYTKCytokinetics
- GKOSGlaukos
- GRALGRAIL
- HAEHaemonetics
- HIMSHims & Hers Health
- HQYHealthEquity
- IOVAIovance Biotherapeutics
- KRYSKrystal Biotech
- KYMRKymera Therapeutics
- LGNDLigand Pharmaceuticals
- LNTHLantheus
- MMEDMiniMed
- MMSIMerit Medical Systems
- OSCROscar Health
- PCVXVaxcyte
- PRAXPraxis Precision Medicines
- PTGXProtagonist Therapeutics
- RYTMRhythm Pharmaceuticals
- SYRESpyre Therapeutics
- TGTXTG Therapeutics
- TWSTTwist Bioscience
- TXG10x Genomics